Jeroen Elassaiss-Schaap

Driving drug development forward through quantitative pharmacology. With this passion my clients overcome hurdles in their projects. By for example selecting the right dose or designing the right trial.

View articles by Jeroen Elassaiss-Schaap

How abnormal is the log? Close-up and personal

How abnormal is the log? Close-up and…

February 13, 2024

58 likes13 comments

“Your antropomorphometrics, pigmentation levels and cumulative number of heart beats or their correlates are irrelevant.”

“Your antropomorphometrics, pigmentation…

January 23, 2024

24 likes7 comments

Open pharmacometrics position at PD-value

Open pharmacometrics position at PD-value

January 18, 2021

22 likes

Open pharmacometrics position at PD-value

Open pharmacometrics position at PD-value

November 15, 2018

13 likes

New approach in multivariate PK-PD modeling: integration with metabolomics

New approach in multivariate PK-PD modeling:…

December 11, 2017

31 likes

New paper on Tumor Size Dynamics in Pembrolizumab-Treated Melanoma

New paper on Tumor Size Dynamics in…

December 8, 2016

50 likes3 comments

New Paper on Translational PK-PD of Tumor Growth in Support of Dose Range Selection Pembrolizumab

New Paper on Translational PK-PD of Tumor…

November 10, 2016

44 likes

New Paper on Model-Based “Learn & Confirm” Cycle in Support of Pembrolizumab Drug Development

New Paper on Model-Based “Learn & Confirm”…

November 10, 2016

38 likes

翻译：